FindTrial
Sign In

CTx-1301 - Dexmethylphenidate 37.5mg

DRUG2 trials

Sponsors

Cingulate Therapeutics

Conditions

ADHDADHD - Combined TypeAttention Deficit Disorder With HyperactivityAttention Deficit Hyper ActivityAttention Deficit Hyperactivity DisorderAttention Deficit Hyperactivity Disorder CombinedAttention-deficit Hyperactivity

Phase 3

Phase 3 Efficacy and Safety Study in Adults With ADHD Using CTx-1301.
CompletedNCT05631626
Cingulate TherapeuticsADHD, ADHD - Combined Type, Attention Deficit Hyperactivity Disorder +1
Start: 2022-12-29End: 2023-06-13Updated: 2026-07-02
Phase 3 Efficacy and Safety Laboratory Classroom Study in Pediatrics (6-12) With ADHD Using CTx-1301
SuspendedNCT05924594
Cingulate TherapeuticsADHD, ADHD - Combined Type, Attention Deficit Disorder With Hyperactivity +4
Start: 2023-07-31End: 2027-02-01Updated: 2026-05-05